Search - tctmd.com

Displaying 1 - 20 of 30

Sort: Relevancy | Date

Presentation ISET 2019

5-Year Results from the IN.PACT SFA Randomized Trial

Presenter: Gary Ansel

January 30, 2019

Presentation ISET 2019

Drug-Coated Therapy for ISR: Review of Options and Data

Presenter: Brian DeRubertis

January 30, 2019

Presentation ISET 2018

Current Management of Superficial Femoral Artery (SFA) and the Data That Got Us There

Presenter: Gary Ansel

February 03, 2018

Presentation VIVA 2017

Results from the IN.PACT SFA Randomized Trial

Presenter: Peter A. Schneider

September 15, 2017

Presentation CCVVC 2016

Use of Drug Eluting Stents in the SFA: What are the Current Data, Real World Applications, Upcoming Trials

Presenter: Tyrone Collins

June 15, 2016

Presentation ISET 2016

Successfully Traversing the Occluded SFA Stent with a Mid-Stent Puncture

Presenter: Gary M. Ansel

February 07, 2016

Presentation ISET 2016

Drug-Coated Balloons in the SFA: A Class of Devices with Differentiated Outcomes?

Presenter: Thomas Zeller

February 07, 2016

Presentation CCVVC 2015

My Algorithm for Treatment of Calcified SFA Lesions: Available Data, Role of DCB - DES, Atherectomy & Supera

Presenter: Fabrizio Fanelli

June 18, 2015

Presentation CCVVC 2015

Endovascular Management of SFA Instent Restenosis: Role of Atherectomy Drug-Eluting Stents

Presenter: Craig M. Walker

June 18, 2015

Presentation CCVVC 2015

Drug Eluting Stents in the treatment of SFA disease: Data and Current Trends

Presenter: Suhail Dohad

June 18, 2015

Presentation CCVVC 2015

Drug Coated Balloon in the Management of SFA Disease: Data & Current Trends

Presenter: Fabrizio Fanelli

June 18, 2015

Presentation ISET 2015

Recanalization of SFA Popliteal Arteries: Flossing and Other Solutions

Presenter: Alan H. Matsumoto

February 02, 2015

Presentation ISET 2015

New Insights from the IN.PACT SFA Randomized Trial

Presenter: Gunnar Tepe

February 02, 2015

Presentation ISET 2015

Benefits of DCB in SFA Disease

Presenter: Thomas Zeller

February 01, 2015

Presentation

German Multicenter Real-World Registry of Stenting for SFA Disease

Presenter: Hans Krankenberg

October 01, 2014

Presentation TCT 2014

Master Class in SFA Technologies: Lining up the Data

Presenter: Robert M. Bersin, Dierk Scheinert, Roger Gammon, William A. Gray

September 13, 2014

Presentation

Randomized Trial of IN.PACT Admiral DCB vs PTA for Atherosclerotic Lesions in the SFA and/or PPA

Presenter: Gunnar Tepe

April 14, 2014

Presentation

Evaluation of the Biodegradable Peripheral Igaki-Tamai Stent in the Treatment of SFA de novo Lesions

Presenter: Martin Werner

February 19, 2014

Presentation TCT 2013

SFA and Tibioperoneal Alternatives: Tailoring Therapeutic Choices

Presenter: Thomas Zeller

October 30, 2013

Presentation TCT 2013

Stenting Is the First-line Treatment for SFA Disease!

Presenter: J. Michael Bacharach

October 27, 2013

Advertisement

5-Year Results from the IN.PACT SFA Randomized Trial

Drug-Coated Therapy for ISR: Review of Options and Data

Current Management of Superficial Femoral Artery (SFA) and the Data That Got Us There

Results from the IN.PACT SFA Randomized Trial

Use of Drug Eluting Stents in the SFA: What are the Current Data, Real World Applications, Upcoming Trials

Successfully Traversing the Occluded SFA Stent with a Mid-Stent Puncture

Drug-Coated Balloons in the SFA: A Class of Devices with Differentiated Outcomes?

My Algorithm for Treatment of Calcified SFA Lesions: Available Data, Role of DCB - DES, Atherectomy & Supera

Endovascular Management of SFA Instent Restenosis: Role of Atherectomy Drug-Eluting Stents

Drug Eluting Stents in the treatment of SFA disease: Data and Current Trends

Drug Coated Balloon in the Management of SFA Disease: Data & Current Trends

Recanalization of SFA Popliteal Arteries: Flossing and Other Solutions

New Insights from the IN.PACT SFA Randomized Trial

Benefits of DCB in SFA Disease

German Multicenter Real-World Registry of Stenting for SFA Disease

Master Class in SFA Technologies: Lining up the Data

Randomized Trial of IN.PACT Admiral DCB vs PTA for Atherosclerotic Lesions in the SFA and/or PPA

Evaluation of the Biodegradable Peripheral Igaki-Tamai Stent in the Treatment of SFA de novo Lesions

SFA and Tibioperoneal Alternatives: Tailoring Therapeutic Choices

Stenting Is the First-line Treatment for SFA Disease!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content